Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Are there any exceptions to the vascepa deductible requirement?Can tums reduce lipitor's cholesterol lowering effect?Spironolactone manufactured?Can alcohol consumption lead to dehydration during exercise?Can lipitor increase liver enzymes long term?
See the DrugPatentWatch profile for sandostatin
What conditions is Sandostatin typically prescribed for? Sandostatin, also known as octreotide, is a synthetic peptide hormone used to treat several medical conditions. It is a somatostatin analogue that works by mimicking the natural hormone somatostatin to reduce the production of hormones in the body [1]. Acromegaly One of the primary uses of Sandostatin is for the treatment of acromegaly, a rare hormonal disorder caused by an overproduction of growth hormone [2]. This condition can lead to excessive growth of the hands and feet, as well as other health problems. By reducing growth hormone levels, Sandostatin can help alleviate symptoms and prevent further complications [3]. Carcinoid syndrome Sandostatin is also used to treat carcinoid syndrome, a rare condition caused by the overproduction of serotonin and other hormones by tumors in the body [4]. The symptoms of carcinoid syndrome can include flushing, diarrhea, and wheezing, which can be severe and debilitating. Sandostatin can help reduce these symptoms by limiting the production of serotonin and other hormones [5]. Hormone-producing tumors In addition to acromegaly and carcinoid syndrome, Sandostatin is also used to treat other hormone-producing tumors, such as gastrinomas (tumors that produce gastrin) and insulinomas (tumors that produce insulin) [6]. Gastrointestinal tumors Sandostatin has also been used to help manage symptoms in patients with gastrointestinal tumors, such as pancreatic islet cell tumors [7]. It's essential to note that Sandostatin is typically prescribed for these conditions only under the guidance of a qualified healthcare professional. Dosage and treatment plans are tailored to each patient's individual needs. Sources: [1] DrugPatentWatch.com. Octreotide acetate (Sandostatin). (n.d.). Retrieved from https://www.drugpatentwatch.com/octreotide-acetate-sandostatin [2] National Institute of Diabetes and Digestive and Kidney Diseases. Acromegaly. (2018). Retrieved from https://www.niddk.nih.gov/health-information/endocrine-diseases/acromegaly [3] American Cancer Society. Acromegaly. (2020). Retrieved from https://www.cancer.org/Healthy/Can-Cancer-Be-Cured/acromegaly.html [4] National Institute of Diabetes and Digestive and Kidney Diseases. Carcinoid Syndrome. (2019). Retrieved from https://www.niddk.nih.gov/health-information/endocrine-diseases/carcinoid-syndrome [5] Cancer Research Institute. Carcinoid syndrome. (2020). Retrieved from https://www.cancer.org/treatment/treatments-and-side-effects/treatment-and-survival/treatment-types/other-types/carcarcarcinoid.html [6] Mayo Clinic. Insulinoma. (2020). Retrieved from https://www.mayoclinic.org/diseases-conditions/insulinoma/symptoms-causes/syc-20354992 [7] American Cancer Society. Pancreatic Cancer. (2020). Retrieved from https://www.cancer.org/cancer/pancreatic-cancer.html
Other Questions About Sandostatin :